Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study.

Hadi Alijanvand M, Aminorroaya A, Kazemi I, Aminorroaya Yamini S, Janghorbani M, Amini M, Mansourian M.

Diabetes Metab Syndr Obes. 2019 Jul 15;12:1123-1139. doi: 10.2147/DMSO.S189726. eCollection 2019.

2.

Different metabolic/obesity phenotypes are differentially associated with development of prediabetes in adults: Results from a 14-year cohort study.

Haghighatdoost F, Amini M, Aminorroaya A, Abyar M, Feizi A.

World J Diabetes. 2019 Jun 15;10(6):350-361. doi: 10.4239/wjd.v10.i6.350.

3.

Probiotic and synbiotic supplementation could improve metabolic syndrome in prediabetic adults: A randomized controlled trial.

Kassaian N, Feizi A, Aminorroaya A, Amini M.

Diabetes Metab Syndr. 2018 Jul 30. pii: S1871-4021(18)30283-2. doi: 10.1016/j.dsx.2018.07.016. [Epub ahead of print]

PMID:
30076087
4.

Factors associated with progression to pre-diabetes: a recurrent events analysis.

Mansourian M, Yazdani A, Faghihimani E, Aminorraya A, Amini M, Jafari-Koshki T.

Eat Weight Disord. 2018 Jun 22. doi: 10.1007/s40519-018-0529-7. [Epub ahead of print]

PMID:
29931448
5.

The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial.

Kassaian N, Feizi A, Aminorroaya A, Jafari P, Ebrahimi MT, Amini M.

Acta Diabetol. 2018 Oct;55(10):1019-1028. doi: 10.1007/s00592-018-1175-2. Epub 2018 Jun 22.

PMID:
29931423
6.

Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan diabetes prevention study.

Janghorbani M, Soltanian N, Amini M, Aminorroaya A.

Diabetes Metab Syndr. 2018 Sep;12(5):715-719. doi: 10.1016/j.dsx.2018.04.019. Epub 2018 Apr 21.

PMID:
29699950
7.

Risk modeling in prospective diabetes studies: Association and predictive value of anthropometrics.

Jafari-Koshki T, Arsang-Jang S, Aminorroaya A, Mansourian M, Amini M.

Diabetes Metab Syndr. 2018 Jul;12(4):563-567. doi: 10.1016/j.dsx.2018.03.027. Epub 2018 Apr 3.

PMID:
29650347
8.

Relationship Between Serum Uric Acid and Incident Hypertension in Patients with Type 2 Diabetes.

Janghorbani M, Ghanbari H, Aminorroaya A, Amini M.

Rev Diabet Stud. 2018 Winter;14(4):354-363. doi: 10.1900/RDS.2017.14.354. Epub 2018 Mar 10.

9.

The Effect of Levothyroxine and Selenium versus Levothyroxine Alone on Reducing the Level of Anti-thyroid Peroxidase Antibody in Autoimmune Hypothyroid Patients.

Kachouei A, Rezvanian H, Amini M, Aminorroaya A, Moradi E.

Adv Biomed Res. 2018 Jan 22;7:1. doi: 10.4103/2277-9175.223735. eCollection 2018.

10.

Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors.

Janghorbani M, Aminorroaya A, Amini M.

Int J Hypertens. 2017;2017:3132729. doi: 10.1155/2017/3132729. Epub 2017 Dec 20.

11.

Area under the curve during OGTT in first-degree relatives of diabetic patients as an efficient indicator of future risk of type 2 diabetes and prediabetes.

Feizi A, Meamar R, Eslamian M, Amini M, Nasri M, Iraj B.

Clin Endocrinol (Oxf). 2017 Dec;87(6):696-705. doi: 10.1111/cen.13443. Epub 2017 Sep 20.

PMID:
28793372
12.

Are body mass index and waist circumference significant predictors of diabetes and prediabetes risk: Results from a population based cohort study.

Haghighatdoost F, Amini M, Feizi A, Iraj B.

World J Diabetes. 2017 Jul 15;8(7):365-373. doi: 10.4239/wjd.v8.i7.365.

13.

Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension.

Janghorbani M, Salamat MR, Aminorroaya A, Amini M.

Endocrinol Metab (Seoul). 2017 Jun;32(2):221-229. doi: 10.3803/EnM.2017.32.2.221. Epub 2017 May 19.

14.

Risk of diabetes according to the metabolic health status and degree of obesity.

Janghorbani M, Salamat MR, Amini M, Aminorroaya A.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S439-S444. doi: 10.1016/j.dsx.2017.03.032. Epub 2017 Apr 1.

PMID:
28404516
15.
16.

The Regenerative Effect of Bone Marrow-Derived Stem Cells on Cell Count and Survival in Acute Radiation Syndrome.

Aghamir SM, Mehrabani D, Amini M, Mosleh-Shirazi MA, Nematolahi S, Shekoohi-Shooli F, Mortazavi SM, Razeghian Jahromi I.

World J Plast Surg. 2017 Jan;6(1):111-113. No abstract available.

17.

Comparison of Different Obesity Indices for Predicting Incident Hypertension.

Janghorbani M, Aminorroaya A, Amini M.

High Blood Press Cardiovasc Prev. 2017 Jun;24(2):157-166. doi: 10.1007/s40292-017-0186-3. Epub 2017 Feb 4.

PMID:
28160265
18.

Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study.

Janghorbani M, Amini M, Aminorroaya A.

Rev Diabet Stud. 2016 Summer-Fall;13(2-3):187-196. doi: 10.1900/RDS.2016.13.187. Epub 2016 Aug 10.

19.

Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial.

Kachuei A, Amini M, Sebghatollahi V, Feizi A, Hamedani P, Iraj B.

J Res Med Sci. 2016 Feb 23;21:8. eCollection 2016.

20.

Utility of hypertriglyceridemic waist phenotype for predicting incident type 2 diabetes: The Isfahan Diabetes Prevention Study.

Janghorbani M, Amini M.

J Diabetes Investig. 2016 Nov;7(6):860-866. doi: 10.1111/jdi.12520. Epub 2016 Apr 20.

21.

The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition.

Sheikhbahaie F, Amini M, Gharipour M, Aminoroaya A, Taheri N.

Adv Biomed Res. 2016 Aug 30;5:145. doi: 10.4103/2277-9175.187401. eCollection 2016.

22.

Association of waist and hip circumference and waist-hip ratio with type 2 diabetes risk in first-degree relatives.

Jafari-Koshki T, Mansourian M, Hosseini SM, Amini M.

J Diabetes Complications. 2016 Aug;30(6):1050-5. doi: 10.1016/j.jdiacomp.2016.05.003. Epub 2016 May 7.

PMID:
27311785
23.

Predictors of all-cause and cardiovascular-specific mortality in type 2 diabetes: A competing risk modeling of an Iranian population.

Sadeghpour S, Faghihimani E, Hassanzadeh A, Amini M, Mansourian M.

Adv Biomed Res. 2016 May 11;5:82. doi: 10.4103/2277-9175.182213. eCollection 2016.

24.

The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study.

Davari M, Boroumand Z, Amini M, Aslani A, Hosseini M.

Int J Prev Med. 2016 May 4;7:72. doi: 10.4103/2008-7802.181758. eCollection 2016.

25.

The Visceral Adiposity Index in Comparison with Easily Measurable Anthropometric Markers Did Not Improve Prediction of Diabetes.

Janghorbani M, Amini M.

Can J Diabetes. 2016 Oct;40(5):393-398. doi: 10.1016/j.jcjd.2016.02.008. Epub 2016 Apr 28.

PMID:
27133398
26.

Effect of the co-administration of glucose with morphine on glucoregulatory hormones and causing of diabetes mellitus in rats.

Radahmadi M, Sharifi MR, Amini M, Fesharaki M.

Adv Biomed Res. 2016 Feb 8;5:21. doi: 10.4103/2277-9175.175907. eCollection 2016.

27.

Trends of diabetic nephropathy prevalence in Isfahan, Iran, during 1992-2010.

Jafari-Koshki T, Hosseini SM, Arsang-Jang S, Amini M, Faghihimani E.

J Res Med Sci. 2015 Oct;20(10):944-9. doi: 10.4103/1735-1995.172781.

28.

Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients.

Khalilzade SH, Aminorroaya A, Hovsepain S, Amini M.

Adv Biomed Res. 2015 Nov 30;4:253. doi: 10.4103/2277-9175.170678. eCollection 2015.

29.

Utility of serum lipid ratios for predicting incident type 2 diabetes: the Isfahan Diabetes Prevention Study.

Janghorbani M, Amini M.

Diabetes Metab Res Rev. 2016 Sep;32(6):572-80. doi: 10.1002/dmrr.2770. Epub 2016 Jan 26.

PMID:
26663847
30.

Risk of diabetes in combined metabolic abnormalities and body mass index categories.

Janghorbani M, Soltanian N, Sirous M, Amini M, Iraj B.

Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S71-8. doi: 10.1016/j.dsx.2015.09.020. Epub 2015 Oct 9.

PMID:
26610402
31.

Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study.

Janghorbani M, Amini M.

Ann Nutr Metab. 2016;68(1):19-25. doi: 10.1159/000441851. Epub 2015 Nov 12.

PMID:
26559166
32.

Current status of glucose, blood pressure and lipid management in type 2 diabetes clinic attendees in Isfahan, Iran.

Janghorbani M, Papi B, Amini M.

J Diabetes Investig. 2015 Nov;6(6):716-25. doi: 10.1111/jdi.12349. Epub 2015 Apr 17.

33.

Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats.

Vatandoost N, Amini M, Iraj B, Momenzadeh S, Salehi R.

Gene. 2015 Nov 1;572(1):95-100. doi: 10.1016/j.gene.2015.07.015. Epub 2015 Jul 8.

PMID:
26164754
34.

Impacts of insulin infusion protocol on blood glucose level and outcomes in acute coronary syndrome patients with diabetes mellitus.

Sabouhi F, Maleki M, Amini M, Kerdegari M.

Iran J Nurs Midwifery Res. 2015 May-Jun;20(3):304-8.

35.

Adherence to statin therapy in patients with type 2 diabetes: An important dilemma.

Farsaei S, Sabzghabaee AM, Amini M, Zargarzadeh AH.

J Res Med Sci. 2015 Feb;20(2):109-14.

36.

Iranian risk model as a predictive tool for retinopathy in patients with type 2 diabetes.

Azizi-Soleiman F, Heidari-Beni M, Ambler G, Omar R, Amini M, Hosseini SM.

Can J Diabetes. 2015 Oct;39(5):358-63. doi: 10.1016/j.jcjd.2015.01.290. Epub 2015 Mar 30.

PMID:
25837808
37.

Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.

Janghorbani M, Amini M.

Diabetes Res Clin Pract. 2015 Jun;108(3):414-22. doi: 10.1016/j.diabres.2015.03.002. Epub 2015 Mar 13.

PMID:
25814432
38.

Glucose and the risk of hypertension in first-degree relatives of patients with type 2 diabetes.

Janghorbani M, Bonnet F, Amini M.

Hypertens Res. 2015 May;38(5):349-54. doi: 10.1038/hr.2015.10. Epub 2015 Feb 19.

PMID:
25693857
39.

Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial.

Karimifar M, Aminorroaya A, Amini M, Mirfendereski T, Iraj B, Feizi A, Norozi A.

J Res Med Sci. 2014 Nov;19(11):1019-26.

40.

The product of triglycerides and glucose in comparison with fasting plasma glucose did not improve diabetes prediction.

Janghorbani M, Almasi SZ, Amini M.

Acta Diabetol. 2015 Aug;52(4):781-8. doi: 10.1007/s00592-014-0709-5. Epub 2015 Jan 10.

PMID:
25572334
41.
42.

Evaluation of peripheral arterial disease in prediabetes.

Faghihimani E, Darakhshandeh A, Feizi A, Amini M.

Int J Prev Med. 2014 Sep;5(9):1099-105.

43.

Retinopathy risk factors in type II diabetic patients using factor analysis and discriminant analysis.

Tazhibi M, Sarrafzade S, Amini M.

J Educ Health Promot. 2014 Aug 28;3:85. doi: 10.4103/2277-9531.139251. eCollection 2014.

44.

Low-density lipoprotein cholesterol and metabolic syndrome in an Iranian high-risk population.

Janghorbani M, Amini M.

Diabetes Metab Syndr. 2015 Apr-Jun;9(2):91-7. doi: 10.1016/j.dsx.2014.07.003. Epub 2014 Aug 6.

PMID:
25108602
45.

Serum uric acid level and its association with cardiometabolic risk factors in prediabetic subjects.

Iraj B, Feizi A, Abdar-Esfahani M, Heidari-Beni M, Zare M, Amini M, Parsa F.

J Res Med Sci. 2014 Mar;19(3):262-7.

46.

Executive functions and information processing in patients with type 2 diabetes in comparison to pre-diabetic patients.

Nazaribadie M, Amini M, Ahmadpanah M, Asgari K, Jamlipaghale S, Nazaribadie S.

J Diabetes Metab Disord. 2014 Feb 4;13(1):27. doi: 10.1186/2251-6581-13-27.

47.

A hybrid intelligent system for diagnosing microalbuminuria in type 2 diabetes patients without having to measure urinary albumin.

Marateb HR, Mansourian M, Faghihimani E, Amini M, Farina D.

Comput Biol Med. 2014 Feb;45:34-42. doi: 10.1016/j.compbiomed.2013.11.006. Epub 2013 Nov 27.

PMID:
24480161
48.

Finnish Diabetes Risk Score to predict type 2 diabetes in the Isfahan diabetes prevention study.

Janghorbani M, Adineh H, Amini M.

Diabetes Res Clin Pract. 2013 Dec;102(3):202-9. doi: 10.1016/j.diabres.2013.10.018. Epub 2013 Nov 4.

PMID:
24262944
49.

Prevalence of stomach cancer in Shiraz, Southern Iran.

Mehrabani D, Hosseini SV, Rezaianzadeh A, Amini M, Mehrabani G, Tarrahi MJ.

J Res Med Sci. 2013 Apr;18(4):335-7.

50.

Cognitive processes and functions in patients with type 2 diabetes in comparison to pre-diabetic patients.

Nazaribadie M, Asgari K, Amini M, Ahmadpanah M, Nazaribadie M, Jamlipaghale S.

J Res Health Sci. 2013 Sep 17;13(2):208-13.

Supplemental Content

Loading ...
Support Center